Stephanie Coulon
Overview
Explore the profile of Stephanie Coulon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Casteleyn C, Sleeckx N, De Spiegelaere W, Heindryckx F, Coulon S, Van Steenkiste C
Vet J
. 2012 Jul;
195(1):6-7.
PMID: 22795959
No abstract available.
12.
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
Coulon S, Francque S, Colle I, Verrijken A, Blomme B, Heindryckx F, et al.
Cytokine
. 2012 Jun;
59(2):442-9.
PMID: 22658783
The liver is a major target of injury in obese patients. Non-alcoholic fatty liver disease (NAFLD) is present in 60-90% of obese Americans and can range from simple steatosis to...
13.
Battaglia-Brunet F, Crouzet C, Burnol A, Coulon S, Morin D, Joulian C
Water Res
. 2012 May;
46(12):3923-33.
PMID: 22608606
Arsenic (As) is a toxic element frequently present in acid mine waters and effluents. Precipitation of trivalent arsenic sulphide in sulphate-reducing conditions at low pH has been studied with the...
14.
Heindryckx F, Kuchnio A, Casteleyn C, Coulon S, Olievier K, Colle I, et al.
J Hepatol
. 2012 Mar;
57(1):61-8.
PMID: 22420978
Background & Aims: The two major primary liver cancers in adults are hepatocellular carcinoma and cholangiocarcinoma. These tumors rapidly outgrow their vascular supply and become hypoxic, resulting in the production...
15.
Van Steenkiste C, Ribera J, Geerts A, Pauta M, Tugues S, Casteleyn C, et al.
Hepatology
. 2011 Apr;
53(5):1629-40.
PMID: 21520176
Unlabelled: Placental growth factor (PlGF) is associated selectively with pathological angiogenesis, and PlGF blockade does not affect the healthy vasculature. Anti-PlGF is therefore currently being clinically evaluated for the treatment...
16.
Coulon S, Heindryckx F, Geerts A, Van Steenkiste C, Colle I, Van Vlierberghe H
Liver Int
. 2010 Nov;
31(2):146-62.
PMID: 21073649
Nowadays, liver cancer, cirrhosis and other liver-related diseases are the fifth most common cause of mortality in the UK. Furthermore, chronic liver diseases (CLDs) are one of the major causes...